{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04575",
    "Peptide Name": "Cnd-m3a (Chionodracine analog, synthetic AMPs, Lys-rich, UCLL1)",
    "Source": "amino acid substitution, animal-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "WFGKLYRGKTKVVKKVKGLLKG",
    "Sequence Length": 22,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 8,
    "Boman Index": 0.93,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "36%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (95.45%) toKHS-Cnd F1W, Chionodracine analogK: 32%, G: 18%, V=L: 14%.Activity: active against K. pneumoniae KPC (MIC 12.5-25 ug/ml), ESBL E. coli (MIC 6.25 ug/ml), XDR A. baumannii (MIC 3.1-6.25 ug/ml), MDR P. aeruginosa (MIC 12.5 ug/ml), S. aureus MRSA (MIC25-50 ug/ml), S. epidermidis (MIC 25 ug/ml), and E. faecalis anti-VRE (MIC 25-50 ug/ml).  In total, 70 clinical strains were tested and the results are expressed as a range.MOA:bacteria:E. coli: it permeated bacterial membranes.In vitro toxicity: human RBC: ~30% hemolysis at 50 uM.Structure:  random coil in both PBS buffer or POPC (1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) LUVs ((Large Unilamellar Vesicles).",
    "Author": "Buonocore F, Picchietti S, Porcelli F, Della Pelle G, Olivieri C, Poerio E, Bugli F, Menchinelli G, Sanguinetti M, Bresciani A, Gennari N, Taddei AR, Fausto AM, Scapigliati G. 2019",
    "Reference": "Dev Comp Immunol. 2019 Jul;96:9-17. doi: 10.1016/j.dci.2019.02.012.PubMed",
    "Title": "Fish-derived antimicrobial peptides: Activity of a chionodracine mutant against bacterial models and human bacterial pathogens."
  },
  "3D Structure": []
}